Literature DB >> 2567381

Discrepancies between the effects of coronary reperfusion on survival and left ventricular function.

F Van de Werf1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2567381     DOI： 10.1016/s0140-6736(89)92812-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery.

Authors:  M Faraggi; G Montalescot; L Sarda; J F Heintz; D Doumit; G Drobinski; I Sotirov; D Le Guludec; D Thomas
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

2.  Left ventricular remodelling after myocardial infarction: importance of residual myocardial viability and ischaemia.

Authors:  C A Visser
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

3.  Intraoperative evaluation of revascularization effect on ischemic muscle hemodynamics using near-infrared diffuse optical spectroscopies.

Authors:  Guoqiang Yu; Yu Shang; Youquan Zhao; Ran Cheng; Lixin Dong; Sibu P Saha
Journal:  J Biomed Opt       Date:  2011-02       Impact factor: 3.170

Review 4.  Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.

Authors:  K L Goa; J M Henwood; J F Stolz; M S Langley; S P Clissold
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

5.  The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation).

Authors:  P Chareonthaitawee; R J Gibbons; R S Roberts; T F Christian; R Burns; S Yusuf
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

Review 6.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

7.  Free radical activity and left ventricular function after thrombolysis for acute infarction.

Authors:  S W Davies; K Ranjadayalan; D G Wickens; T L Dormandy; V Umachandran; A D Timmis
Journal:  Br Heart J       Date:  1993-02

Review 8.  Alteplase. A reappraisal of its pharmacological properties and therapeutic use in acute myocardial infarction.

Authors:  J C Gillis; A J Wagstaff; K L Goa
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

9.  Where does the Occluded Artery Trial leave the late open artery hypothesis?

Authors:  Gervasio A Lamas; Judith S Hochman
Journal:  Heart       Date:  2007-11       Impact factor: 5.994

10.  Quantitative evaluation of the amount of delayed myocardial enhancement as a predictor of systolic dysfunction.

Authors:  J E Shriki; K Surti; A Farvid; J S Shinbane; P M Colletti
Journal:  Open Cardiovasc Med J       Date:  2009-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.